Product Information
GABAPENTIN 800 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0963 per EA under NDC 50228017801. Its NADAC has been published 380 times since Mar 20, 2019.
The High Outlier badge above means this manufacturer's average price in the Gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
800 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228017801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA205101On Market Since
2/4/2016
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 800 MG TABLET has been published 380 times since Mar 20, 2019, and over the history we have for it it has declined 21.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0963 per EA |
|---|---|
| All-time high | $0.1374 (Jan 15, 2020) |
| All-time low | $0.0799 (Nov 20, 2024) |
| 52-week high | $0.1035 |
| 52-week low | $0.0963 |
| Median price | $0.1238 |
| Average price | $0.1187 |
| Largest weekly change | -27.0% (Nov 20, 2024) |
| Weeks tracked | 380 |
| Tracking since | Mar 20, 2019 |
Generic Alternatives
The matcher finds 21 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0963 per EA (NDC 50228017801), effective Jun 24, 2026.
How has the price of GABAPENTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 21.7%. It has been tracked across 380 weekly CMS publications since Mar 20, 2019.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?
Since Mar 20, 2019, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1374 (Jan 15, 2020), with a median of $0.1238 per EA.
Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?
21 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 800 MG TABLET, but none are currently priced below it.
Who manufactures GABAPENTIN 800 MG TABLET?
GABAPENTIN 800 MG TABLET (NDC 50228017801) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification